Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
159
NCT02993055
A Study to Assess Ulimorelin in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 31, 2015
Completion: Nov 30, 2015
NCT02784392
Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial
Phase: Phase 2
Start: Oct 31, 2016
Completion: Mar 31, 2018